Pharmacovigilance [Pharmacovigilance update]

Details

Serval ID
serval:BIB_C927A68F240C
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Pharmacovigilance [Pharmacovigilance update]
Journal
Revue Médicale Suisse
Author(s)
Livio F., Buclin T., Biollaz J.
ISSN
1660-9379
Publication state
Published
Issued date
2008
Volume
4
Number
140
Pages
150-154
Language
french
Abstract
The observations of pharmacovigilance reported during 2007 reflect an increasing attention towards drug-induced augmentation of the incidence of common disorders. New substances are thus to be added to the list of risk factors susceptible to favour cardiovascular events (tegaserod, rosiglitazone, erythropoietin, aprotinine) or psychiatric disorders (dopaminergic agonists, rimonabant). The evaluation of the security profile of new medicines remains challenging. Besides biological investigations of questionable relevance and clinical trial of inconstant efficiency towards safety outcomes, the role of pharmacovigilance notifications by practitioners remains of paramount importance
Keywords
administration & dosage, adverse effects, agonists, Attention, chemically induced, Depression, Heart Diseases, Humans, Incidence, Neuromuscular Diseases, Pharmaceutical Preparations, Risk, Risk Factors, Role
Pubmed
Create date
29/01/2009 23:12
Last modification date
19/02/2021 7:26
Usage data